Immucell (ICCC) executive compensation, 2026 proxy

Paul Olivier te Boekhorst, President and Chief Executive Officer, was paid $675,934 in 2025.

Filed
April 24, 2026
Annual meeting
June 11, 2026
Pay year
2025
Named executives
4
CEO total pay
$675,9342025
CEO Base Salary
$450,000Annualized under new agreement
CEO Sign-on Bonus
$100,000Paid upon commencement
Former CEO Total Pay
$831,009Includes $300,000 deferred comp payout

How Boekhorst was paid

$675,934 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary10%Bonus15%Option awards74%All other compensation1%

Named executive officers

ExecutiveTotal
Paul Olivier te BoekhorstPresident and Chief Executive Officer$675,934
Michael F. BrighamFormer President, Chief Executive Officer, Treasurer and Secretary$831,009
Bobbi Jo BrockmannSenior Vice President of Sales and Marketing$441,316
Timothy C. FioriChief Financial Officer, Treasurer and Secretary$369,444

What changed and why

  • $676KP. Olivier te Boekhorst joined as CEO in November 2025 with a total compensation of $675,934.
  • $831KMichael F. Brigham received $831,009 in total compensation during his transition year as former CEO.
  • $250KTimothy C. Fiori was appointed as Chief Financial Officer with an initial base salary rate of $250,000.
  • $441KBobbi Jo Brockmann earned total compensation of $441,316 as Senior Vice President of Sales and Marketing.
  • Stock options serve as the sole outstanding form of equity awards for employees and directors.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.